WHO identifies Ebola treatments, urgesvaccines be tested in trials

The World Health Organization recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola, including ‌Mapp Biopharmaceutical's MBP134, Regeneron's maftivimab and Gilead Sciences' antiviral remdesivir. The WHO…

Go to News Site